Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P04626 (erbB-2)
 5,251 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Twenty cases of primary Fallopian tube endometrioid carcinoma (PFTEC) are presented in the paper. This accounts for 42.5% of all histologic forms of primary Fallopian tube carcinoma (PFTC) found in our Department. The youngest patient was 38, and the oldest 68 years (mean: 56 years). Seven patients were nulliparas. Only two cases were bilateral. According to FIGO staging, 13 cases were evaluated as stage I, 4 as II, and 3 as stage III. Due to the histologic grading, 8 tumors were classified as well, 7 as moderately, and 5 as poorly differentiated. In the time of preparation of the manuscript, 12 women were still alive, 2 of them with recurrent disease. The follow-up of patients without recurrence ranged from 4 to 120 months (median: 63). Eight patients had died (survival time: from 4 to 65 months; median: 26). Metastases were found in 8 patients, especially to ovaries. In 14/20 cases of PFTEC various forms of tubal wall invasion were observed. Blood or lymphatic vessels involvement was found in 9 patients. Six of them had died and one is alive with the symptoms of disease. Immunohistochemical detection of the mutant form of p53 protein and oncogene product, c-erbB-2, was studied in 17 cases. Nine patients exhibited simultaneous p53 protein accumulation and c-erbB-2 expression. 2/9 of these patients are alive with recurrent tumors and 4/9 died. Endometrioid carcinoma of the Fallopian tube can be characterized by a tendency to superficial invasion of tubal wall and in a half of the cases by invasion of vessels. The majority of these tumors were diagnosed at an early stage tumors.
 ...
PMID:Primary endometrioid carcinoma of fallopian tube. Clinicomorphologic study. 1007 81

The aim of this study was to investigate the occurrence of (pre)neoplastic lesions in overtly normal Fallopian tubes from women predisposed to developing ovarian carcinoma. The presence of (pre)neoplastic lesions was scored in histological specimens from 12 women with a genetically determined predisposition for ovarian cancer, of whom seven tested positive for a germline BRCA1 mutation. A control group included 13 women. Immunohistochemistry was used to determine the expression of p21, p27, p53, cyclin A, cyclin D1, bcl-2, Ki67, HER-2/neu, and the oestrogen and progesterone receptors. Loss of heterozygosity (LOH) analysis on the BRCA1 locus was also assessed on dysplastic tissue by PCR studies. Of the 12 women with a predisposition for ovarian cancer, six showed dysplasia, including one case of severe dysplasia. Five harboured hyperplastic lesions and in one woman no histological aberrations were found in the Fallopian tube. No hyperplastic, dysplastic or neoplastic lesions were detected in the Fallopian tubes of control subjects. In the cases studied, morphologically normal tubal epithelium contained a higher proportion of Ki67-expressing cells (p=0.005) and lower fractions of cells expressing p21 (p<0.0001) and p27 (p=0.006) than in the control group. Even higher fractions of proliferating cells were found in dysplastic areas (p=0.07) and accumulation of p53 was observed in the severely dysplastic lesion. Expression patterns of other proteins studied, including the hormone receptors, were similar in cases and controls. One subject, a germline BRCA1 mutation carrier, showed loss of the wild-type BRCA1 allele in the severely dysplastic lesion. In conclusion, the Fallopian tubes of women predisposed to developing ovarian cancer frequently harbour dysplastic changes, accompanied by changes in cell-cycle and apoptosis-related proteins, indicating an increased risk of developing tubal cancer.
 ...
PMID:Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. 1174 77

Primary Fallopian tube carcinoma (PFTC) is one of the rarest malignant tumours of the female genital tract. Staging of the disease according to FIGO scale is the most common prognostic indicator. Others, such as histological type, grading according to Hu classification, depth of tubal wall invasion, the presence of neoplastic cells in peritoneal leakage, invasion of the lymphatic and blood vessels, mitotic activity, DNA ploidy, Ki-67 expression, AgNOR level and p53 and c-erbB-2 immunoreactivity, are not widely accepted. 70 cases of primary Fallopian tube carcinomas were analysed with regard to clinicopathological data, survival and the expression of proliferating cell nuclear antigen (PCNA) and laminin. Histological classification of PTFC revealed 26 cases of the endometriod type, 16 undifferentiated, 15 serous, 8 urothelial, 3 clearcell and 3 of other types. A total of 70 cases revealed positive nuclear staining for PCNA. The index of PCNA (labelling index, LI, proportion of PCNA-positive cells relative to all neoplastic cells) was evaluated. PCNA LI values were classified as high, > 0.45, or low, </= 0.45. Intracellular expression of laminin was found in 46 cases and extracellular in 28 cases. There was no significant correlation between the expression and distribution of laminin and survival. The p value was statistically significant only for PCNA LI as an independent prognostic factor.
 ...
PMID:PCNA and laminin as prognostic factors in primary Fallopian tube carcinoma. 1465 45